Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Q: How long will it take to read this news story?

The story "Earnings growth priced-in Divi&#039;s Labs stock, niche biz to expand: Analysts" has 773 words across 29 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Earnings growth priced-in Divi&#039;s Labs stock, niche biz to expand: Analysts" was covered 7 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 229 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21925973</li><li>URL: https://beamstart.com/news/earnings-growth-priced-in-divis-17228355892310</li></ul>

Business Standard Logo Business Standard 7h ago

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts - Business Standard

Quick Summary:

Shares of Divis Laboratories fell 2.41 to Rs 4870 per share on the BSE in Monday's intraday deals.

Though, the brokerage was optimistic on the company’s growth outlook, as improvements are seen in peptide, contrast media and other niche segments within the CS business.

Further earnings before interest tax, depreciation and amortisation (Ebitda) also grew by 23 per cent to Rs 622 crore, with a Ebitda margin of 29.4 per cent, up from 28.3 per cent last year.